Synthesis, docking studies, and in silico ADMET predictions of some new derivatives of pyrimidine as potential KSP inhibitors
- 11 July 2014
- journal article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 24 (1) , 304-315
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Structure based virtual screening-driven identification of monastrol as a potent urease inhibitorJournal of Molecular Graphics and Modelling, 2013
- Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1,5-benzothiazepinesBioorganic & Medicinal Chemistry, 2008
- Cytochrome P450 and Chemical ToxicologyChemical Research in Toxicology, 2007
- Targeted anti-mitotic therapies: can we improve on tubulin agents?Nature Reviews Cancer, 2007
- Microwave-Assisted Solution- and Solid-Phase Synthesis of 2-Amino-4-arylpyrimidine DerivativesJournal of Combinatorial Chemistry, 2007
- Pyrimidine as Constituent of Natural Biologically Active CompoundsChemistry & Biodiversity, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugNature Reviews Drug Discovery, 2002
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999
- Synthesis and Biological Activity of Methanesulfonamide Pyrimidine- and N-Methanesulfonyl Pyrrole-Substituted 3,5-Dihydroxy-6-heptenoates, a Novel Series of HMG-CoA Reductase InhibitorsBioorganic & Medicinal Chemistry, 1997